592
Views
22
CrossRef citations to date
0
Altmetric
Review Articles

Passive and semi-active targeting of bone marrow and leukemia cells using anionic low cholesterol liposomes

, &
Pages 797-804 | Received 27 Jan 2016, Accepted 27 Apr 2016, Published online: 16 May 2016

References

  • Wu NZ , Da D , Rudoll TL , et al . Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 1993;53:3765–70.
  • Yuan F , Dellian M , Fukumura D , et al . Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995;55:3752–6.
  • Hwang KJ. Liposome Pharmacokinetics. In: Ostro M , ed. Liposomes: from biophysics to therapeutics. New York: Marcel Dekker; 1987:109–56.
  • Kirby C , Clarke J , Gregoriadis G. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J 1980;186:591–8.
  • Allen TM , Chonn A. Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett 1987;223:42–6.
  • Allen TM , Hansen C. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta 1991;1068:133–41.
  • Lasic DD , Martin FJ , Gabizon A , et al . Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1991;1070:187–92.
  • Allen TM. Long-circulating (sterically stabilized) liposomes for targeted drug delivery . Trends Pharmacol Sci 1994;15:215–20.
  • Woodle MC , Lasic DD. Sterically stabilized liposomes. Biochim Biophys Acta 1992;1113:171–99.
  • Boman N , Cullis P , Mayer L , Bally M , Webb M. Liposomal vincristine: the central role of drug retention in defining therapeutically optimized anticancer formulations. In: Woodle M , Storm G , eds. Long circulating liposomes: old drugs, new therapeutics. Heidelberg, Berlin: Biotechnology Intelligence Unit Springer; 1998:29–49.
  • Hong RL , Huang CJ , Tseng YL , et al . Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? Clin Cancer Res 1999;5:3645–52.
  • Mayer LD , Dougherty G , Harasym TO , Bally MB. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors . J Pharmacol Exp Ther 1997;280:1406–14.
  • Parr MJ , Masin D , Cullis PR , Bally MB. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). J Pharmacol Exp Ther 1997;280:1319–27.
  • Laginha KM , Verwoert S , Charrois GJ , Allen TM. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clinical Cancer Res 2005;11:6944–9.
  • Kirpotin D , Park JW , Hong K , et al . Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Biochemistry 1997;36:66–75.
  • Nellis DF , Ekstrom DL , Kirpotin DB , et al . Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification. Biotechnol Prog 2005;21:205–20.
  • Park JW , Hong K , Kirpotin DB , et al . Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clinical Cancer Res 2002;8:1172–81.
  • Park JW , Kirpotin DB , Hong K , et al . Tumor targeting using anti-her2 immunoliposomes. J Control Release 2001;74:95–113.
  • Dos Santos N , Mayer LD , Abraham SA , et al . Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes. Biochim Biophys Acta 2002;1561:188–201.
  • Tardi PG , Gallagher RC , Johnstone S , et al . Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochim Biophys Acta 2007;1768:678–87.
  • Tardi P , Johnstone S , Harasym N , et al . In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Res 2009;33:129–39.
  • Jain RK , Stylianopoulos T. Delivering nanomedicine to solid tumors. Nature Rev Clin Oncol 2010;7:653–64.
  • Sou K , Goins B , Oyajobi BO , et al . Bone marrow-targeted liposomal carriers. Exp Opin Drug Deliv 2011;8:317–28.
  • Miyazaki Y , Taguchi K , Sou K , et al . Therapeutic impact of erythropoietin-encapsulated liposomes targeted to bone marrow on renal anemia. Mol Pharm 2014;11:4238–48.
  • Bulte JW , de Cuyper M , Despres D , Frank JA. Short-vs long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J Magn Reson Imaging 1999;9:329–35.
  • Sou K. Advanced drug carriers targeting bone marrow. Pharmcol Toxicol Pharmaceut Sci 2012:2012:10–31.
  • Kim DH , Yoo KH , Choi KS , et al . Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine 2005;31:119–26.
  • Tavassoli M. Structure and function of sinusoidal endothelium of bone marrow. Prog Clin Biol Res 1981;59B:249–56.
  • Narayan K , Juneja S , Garcia C. Effects of 5-fluorouracil or total-body irradiation on murine bone marrow microvasculature. Exp Hematol 1994;22:142–8.
  • Fliedner TM , Graessle D , Paulsen C , Reimers K. Structure and function of bone marrow hemopoiesis: mechanisms of response to ionizing radiation exposure . Cancer Biother Radiopharm 2002;17:405–26.
  • Iversen PO. Blood flow to the haemopoietic bone marrow. Acta Physiol Scand 1997;159:269–76.
  • Moghimi SM. Exploiting bone marrow microvascular structure for drug delivery and future therapies. Adv Drug Deliv Rev 1995;17:61–73.
  • Tavassoli M. The marrow-blood barrier. Br J Haematol 1979;41:297–302.
  • Hudson G , Yoffey JM. Ultrastructure of reticuloendothelial elements in guinea-pig bone marrow. J Anatomy 1968;103:515–25.
  • Bankston PW , De Bruyn PP. The permeability to carbon of the sinusoidal lining cells of the embryonic rat liver and rat bone marrow. Am J Anatomy 1974;141:281–5.
  • Porter CJ , Moghimi SM , Illum L , Davis SS. The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett 1992;305:62–6.
  • Awasthi VD , Garcia D , Goins BA , Phillips WT. Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits. Int J Pharmaceut 2003;253:121–32.
  • Huang TS . Passage of foreign particles through the sinusoidal wall of the rabbit bone marrow-an electron microscopic study. Acta Pathol Jpn 1971;21:349–67.
  • Davé UP , Koury MJ. Structure of the marrow and the hematopoietic microenvironment. In: Kaushansky K , Lichtman MA , Prchal JT , Levi MM , Press OW , Burns LJ , et al ., eds. Williams Hematology, 9e. New York: McGraw-Hill Education; 2015.
  • Boerman OC , Oyen WJ , van Bloois L , et al . Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. J Nuclear Med 1997;38:489–93.
  • Allen TM , Austin GA , Chonn A , et al . Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta 1991;1061:56–64.
  • Awasthi VD , Garcia D , Klipper R , et al . Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Therapeut 2004;309:241–8.
  • Schettini DA , Ribeiro RR , Demicheli C , et al . Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced size. Int J Pharmaceut 2006;315:140–7.
  • Sou K , Goins B , Takeoka S , et al . Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo. Biomaterials 2007;28:2655–66.
  • Xia W , Hilgenbrink AR , Matteson EL , et al . A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009;113:438–46.
  • Zhao X , Li H , Lee RJ. Targeted drug delivery via folate receptors. Exp Opin Drug Deliv 2008;5:309–19.
  • Lim WS , Tardi PG , Dos Santos N , et al . Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts. Leukemia Res 2010;34:1214–23.
  • Barth H , Schnober EK , Neumann-Haefelin C , et al . Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J Virol 2008;82:3466–79.
  • Greenwalt DE , Lipsky RH , Ockenhouse CF , et al . Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. Blood 1992;80:1105–15.
  • Kessel D , Hall TC , Rosenthal D. Uptake and phosphorylation of cytosine arabinoside by normal and leukemic human blood cells in vitro. Cancer Res 1969;29:459–63.
  • Tidefelt U , Sundman-Engberg B , Paul C. Intracellular uptake and cytotoxic effect in vitro of doxorubicin and epirubicin in human leukemic and normal hematopoietic cells. Cancer Chemother Pharmacol 1991;29:7–12.
  • Belov L , de la Vega O , dos Remedios CG , et al . Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 2001;61:4483–9.
  • Xu Y , McKenna RW , Wilson KS , et al . Immunophenotypic identification of acute myeloid leukemia with monocytic differentiation. Leukemia 2006;20:1321–4.
  • Casasnovas RO , Slimane FK , Garand R , et al . Immunological classification of acute myeloblastic leukemias: relevance to patient outcome. Leukemia 2003;17:515–27.
  • Banker DE , Mayer SJ , Li HY , et al . Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 2004;104:1816–24.
  • Kim JHT,P , Shin ES , Mayer LD , Wasan KM. Scavenger receptor class B type I (SR-B1) expression levels modulate CPX-351 uptake with cancer cells. Promoting Today's Ideas for Tomorrow's Medicine: Pharmaceutical Science to Regulartory Science. Montreal; 2014:102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.